BELAIRA Trademark

Trademark Overview

On Tuesday, September 18, 2012, a trademark application was filed for BELAIRA with the United States Patent and Trademark Office. The USPTO has given the BELAIRA trademark a serial number of 85731623. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 18, 2016. This trademark is owned by Glaxo Group Limited. The BELAIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
belaira

General Information

Serial Number85731623
Word MarkBELAIRA
Filing DateTuesday, September 18, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 18, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 15, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BELAIRA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, April 18, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 18, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2015EXTENSION 5 GRANTED
Wednesday, July 29, 2015EXTENSION 5 FILED
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 9, 2015EXTENSION 4 GRANTED
Monday, March 2, 2015EXTENSION 4 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Tuesday, September 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 8, 2014EXTENSION 3 GRANTED
Thursday, August 28, 2014EXTENSION 3 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Thursday, April 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 2, 2014EXTENSION 2 GRANTED
Monday, March 3, 2014EXTENSION 2 FILED
Friday, March 28, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 3, 2014TEAS EXTENSION RECEIVED
Friday, September 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2013EXTENSION 1 GRANTED
Wednesday, September 4, 2013EXTENSION 1 FILED
Wednesday, September 4, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 12, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 8, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 4, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 26, 2012EXAMINER'S AMENDMENT ENTERED
Monday, November 26, 2012ASSIGNED TO LIE
Monday, November 26, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 26, 2012EXAMINERS AMENDMENT E-MAILED
Monday, November 26, 2012EXAMINERS AMENDMENT -WRITTEN
Monday, November 26, 2012ASSIGNED TO EXAMINER
Friday, September 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 21, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

belaira pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological